Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTK2 | Q05397 | 2/20 | 0.49 |
| ▸ | UTS2R | Q9UKP6 | 9/20 | 0.48 |
| ▸ | HTR7 | P34969 | 5/20 | 0.48 |
| ▸ | HTR1A | P08908 | 2/20 | 0.47 |
| ▸ | DRD2 | P14416 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6823920 | 0.89 | PTK2 (0.45) | PTK2UTS2RHTR7HTR1A | |
| SCHEMBL6823918 | 0.88 | PTK2 (0.47) | PTK2UTS2RHTR7HTR1A | |
| SCHEMBL6826210 | 0.87 | PTK2 (0.44) | PTK2UTS2RHTR7HTR1ADRD2 | |
| SCHEMBL6381981 | 0.83 | HTR7 (0.49) | UTS2RHTR7HTR1ADRD2HTR2A | |
| SCHEMBL6823956 | 0.82 | HTR7 (0.47) | UTS2RHTR7HTR1ADRD2HTR2A | |
| SCHEMBL6824741 | 0.82 | HTR7 (0.47) | UTS2RHTR7HTR1ADRD2HTR2A | |
| SCHEMBL6823392 | 0.82 | HTR7 (0.49) | UTS2RHTR7HTR1ADRD2HTR2A | |
| SCHEMBL6820545 | 0.81 | HTR7 (0.50) | UTS2RHTR7HTR1ADRD2HTR2A | |
| SCHEMBL6820574 | 0.81 | HTR7 (0.47) | UTS2RHTR7HTR1ADRD2HTR2A | |
| SCHEMBL6823860 | 0.81 | UTS2R (0.49) | UTS2RHTR7HTR1ADRD2HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004076444-A2 | NOVEL HYDROXYCOUMARANONE DERIVATIVES AS ANTITUMOR AND ANTIMETASTATIC | F. HOFFMANN-LA ROCHE AG (CH) | 2004-09-10 | — | — | WO | claimed |
| WO-2004076444-A2 | NOVEL HYDROXYCOUMARANONE DERIVATIVES AS ANTITUMOR AND ANTIMETASTATIC | F. HOFFMANN-LA ROCHE AG (CH) | 2004-09-10 | — | — | WO | disclosed |